Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Reviva Pharmaceuticals Holdings, Inc. (RVPH) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.01M |
|
-- |
|
-- |
|
$4.03M |
|
$-4.03M |
|
$0.02M |
|
$-4.01M |
|
$-4.01M |
|
$-4.01M |
|
$-4.01M |
|
$-4.01M |
|
$-4.01M |
|
$-4.03M |
|
$-4.03M |
|
72.69M |
|
72.69M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$13.51M |
|
-- |
|
$0.82M |
|
$14.33M |
|
$9.74M |
|
-- |
|
$0.04M |
|
$9.78M |
|
$4.55M |
|
$4.55M |
|
$4.55M |
|
96.34M |
|
| Cash Flow Statement Financials | |
$-18.80M |
|
-- |
|
$18.50M |
|
$13.48M |
|
$13.18M |
|
$-0.29M |
|
$1.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.39 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-88.15% |
|
-88.15% |
|
-27.98% |
|
-88.15% |
|
$0.05 |
|
$-0.26 |
|
$-0.26 |
|